Promoter collection, Human APCS promoter
Alternative name | U2671(2049)-7 |
---|---|
Clone info. | PCR amplified human APCS promoter sequence was inserted into a firefly luciferase vector. Cloned fragment: 159586692 to 159587854(NC_000001.11); relatively -1134 to +29, where +1 corresponds to 1 nt of NM_001639.4. |
Comment | PCR cloning, forward primer: CTTGGTGGCAGTGATTGTGT; reverse primer: TGTCCCCCTAGCGTCTGATA. Entire sequence of promoter region has not been confirmed. |
Vector backbone | pGL4.10 [Luc2] (Plasmid) |
Selectable markers | Amp^r |
Gene/insert name | Human amyloid P component, serum genomic DNA |
Depositor|Developer | DNA Bank, | |
Remarks, protocol and/or map (pdf) | RDB07317.pdf |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 謝辞の表明を必要とする。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB07317 | pGL4-phAPCS | DNA solution |
Materials & Methods section:
The pGL4-phAPCS was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07317). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB07317_A4C4.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: Sequence file: RDB07317_A4C4a.seq |
---|
>07317_07317_A4C4_3_pGL4-4174F_C07_07.ab1 1 GACGGGGGTC AGGACATTTC TCGTGGCCTA ACTGGCCGGT ACCTGAGCTC GCTAGCCTCG 61 AGGATCTTGG TGGCAGTGAT TGTGTCATTG AAAAGGCTGA TTAGGTCTGT GGTGAGCTAA 121 CAGAAGAGAG AGTGAACAAG AGGCTAAACA GTAGGATGAG AAACAAGACA CCATATAATT 181 CAGGGATGAG AGAGAAAGAA ATAATGTGGC TAGAAAGAAG AACTTCAGTT TGATATCTCA 241 GAGGCAGAGA AGGTTTGAGT GGTGGTTAAT AAACTGTACA GAGAGAGAAT GAAGGAGACA 301 TAGAAAGAAT GAAGGTGGAG ATCTCTGGGG CTGTGAGAGA GCCAGTGACC ACTGAATCCC 361 CAGCACCTAG TGTAGTAACT GAGAGCTAGT GAATAAATGT ATTAGTGGGG TCATCACCAA 421 AGATGGATTA GATATACACT CAATGACCAA GGACTCAAAG AAGAGGAGAG AAAAACTTGG 481 GGAGATGCTG ACATCTCTGC AGGTAGCATG AAGTAACCAG AAAACAAGTC GTAATGAGAA 541 ATGGAAAGAT CTAGGATAAG GAAGCACCAT GATATGCAAA CGAAAAAAAA GCACTGAGTA 601 GAAGTAGCAG AAAAATACTA AGCTTCATGG GGACAGAAAG TTTATTCTCC AAGTCCCTCT 661 TTCCCCTTAG CTTTGCCTGG ATGTATTACT TGATGTTGAA TTAGTCAAAG TTGAAGGCAC 721 TTTTTAGGGT CTTCAGCAGA AAGCAGAATC CTAGAATATC CTACAAATAC AAGACAACTT 781 GAGAACTATA AAAGAAAGAA AAGGCCTTGT TCCCATAGCC CACAAGAGGG CTGAGCTCAG 841 CGATACACTC TGTGTGGCTC AGGAGCTTCT GGCAGAGCAC AGAGCCATCA GAGAGGGGGG 901 CCCAGAGAGC AGAGAGAGGC TCTGCTGACA TGGCCAGCCC AGCGCCTCAT CCCATCCATA 961 ACCCTGCTGC CCTGCAATGA CTCTCTTTCC CAGCAATAAA ATCTGGGTCA CAGGAGTTGG 1021 GAGCTCTAGC CATCACTTGT CTCTAATAAA TAACTCCCAT TGATTTTCCA GCTCATGCTC 1081 ACACTCCTTT CACGGTAGCG TAAGCAGCAG ACCTGGCAAA AATCACCTCC ACCAATAATT 1141 AATTTGGGGG TGGC // |
Primer: Sequence file: RDB07317_A4C4b.seq |
>07317_07317_A4C4_3_pGL4-136R_F07_16.ab1 1 GCTCTTTAGT TTTTGGCATC TTCCATGGTG GCTTTACCAA CAGTACCGGA TTGCCAAGCT 61 TGGCCGCCGA GGCCAGATCT TGATTGTCCC CCTAGCGTCT GATATTCATG CCCTTAGACT 121 TCAGGTTATT CAGGGTTTAT ATGCACCTTG GGTGAGGATG GGGGAGGAAG AGCACCAATA 181 ATATGTGAGT GATTTTCCAG GTCTGCCTCC TGGCGCTTAC GGTGAAGGAG TGGTGAGCCC 241 TGAGCTGGAA AATCAATGGG AGTTATTTAT TAGAGACAAG TGATGGCTAG AGCTCCAACT 301 CCTGTGACCC AGATTTTATT GCTGGGAAGA GAGTCATTGC AGGGCAGCAG GGTTATGGAT 361 GGGATGAGGC GCTGGGCTGG CCATGTCAGC AGAGCCTCTC TCTGCTCTCT GGGCCCCCTC 421 TCTGATGGCT CTGTGCTCTG CCAGAAGCTC CTGAGCCACA CAGAGTGTAT CGCTGAGCTC 481 AGCCCTCTTG TGGGCTATGG GAACAAGGCC TTTTCTTTCT TTTATAGTTC TCAAGTTGTC 541 TTGTATTTGT AGGATATTCT AGGATTCTGC TTTCTGCTGA AGACCCTAAA AAGTGCCTTC 601 AACTTTGACT AATTCAACAT CAAGTAATAC ATCCAGGCAA AGCTAAGGGG AAAGAGGGAC 661 TTGGAGAATA AACTTTCTGT CCCCATGAAG CTTAGTATTT TTCTGCTACT TCTACTCAGT 721 GCTTTTTTTT CGTTTGCATA TCATGGTGCT TCCTTATCCT AGATCTTTCC ATTTCTCATT 781 ACGACTTGTT TTCTGGTTAC TTCATGCTAC CTGCAGAGAT GTCAGCATCT CCCCAAGTTT 841 TTCTCTCCTC TTCTTTGAGT CCTTGGTCAT TGAGTGTATA TCTAATCCAT CTTTGGTGAT 901 GACCCCACTA ATACATTTAT TCACTAGCTC TCAGTTACTA CACTAGGTGC TGGGGGATTC 961 AGTGGTCACT GGCTCTCTCA CAGCCCCAGA GATCTCCACC TTCATTCTTT CTATGTCTCC 1021 CTTCATTCTC TCTCTGTACA GTTATTTAAA CCACCACTCA AAACCCTTCT CTGCCTCTGA 1081 GAATATCAAA CTGGCAGGTC GTCGTTTCTA GGCCACATAT TTCGTTTCCT CTCTCAATTC 1141 CCCTGTGAT // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content